Manufacturers Life Insurance Company, The Coherus Bio Sciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 37,903 shares of CHRS stock, worth $31,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,903Holding current value
$31,838% of portfolio
0.0%Shares
31 transactions
Others Institutions Holding CHRS
# of Institutions
130Shares Held
67.8MCall Options Held
1.68MPut Options Held
91.8K-
Black Rock Inc. New York, NY11.8MShares$9.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$9.37 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.28MShares$4.44 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.42 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA3.65MShares$3.07 Million0.38% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $65.3M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...